Cas:7399-93-1 Methyl 6-oxo-3,6-dihydropyrimidine-4-carboxylate manufacturer & supplier

We serve Chemical Name:Methyl 6-oxo-3,6-dihydropyrimidine-4-carboxylate CAS:7399-93-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Methyl 6-oxo-3,6-dihydropyrimidine-4-carboxylate

Chemical Name:Methyl 6-oxo-3,6-dihydropyrimidine-4-carboxylate
CAS.NO:7399-93-1
Synonyms:6-Oxo-1,6-dihydro-pyrimidin-4-carbonsaeure-methylester;Methyl6-Hydroxypyrimidine-4-carboxylate;Methyl 6-oxo-1,6-dihydro-4-pyrimidinecarboxylate;methyl 6-oxo-3,6-dihydropyrimidine-4-carboxylate;4-Pyrimidinecarboxylic acid, 3,6-dihydro-6-oxo-, methyl ester;6-oxo-1,6-dihydro-pyrimidine-4-carboxylic acid methyl ester;Methyl 6-oxo-1,6-dihydropyrimidine-4-carboxylate
Molecular Formula:C6H6N2O3
Molecular Weight:154.123
HS Code:2933599090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:263.8±50.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.580
PSA:72.05000
Exact Mass:154.037842
LogP:-1.84

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-Oxo-1,6-dihydro-pyrimidin-4-carbonsaeure-methylester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 6-oxo-1,6-dihydropyrimidine-4-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Oxo-1,6-dihydro-pyrimidin-4-carbonsaeure-methylester Use and application,Methyl6-Hydroxypyrimidine-4-carboxylate technical grade,usp/ep/jp grade.


Related News: Regulators approved the shot in May but paused the deployment amid lingering concerns about blood clots. Japan has so far relied vaccines made by Pfizer Inc (PFE.N) and Moderna Inc (MRNA.O) in its inoculation push. 1-(2,4-dinitrophenyl)-2-(heptylidene-7-d)hydrazine manufacturers As of June’s end, there have been 100 reported GBS cases among J&J recipients, most of whom were hospitalized and one person has died, CDC officials reported. Most cases were seen in older men within 13 days following the single-dose vaccine. (S)-(4-isopropyl-3-methylpiperazin-1-yl)(1-(6-(trifluoromethyl)pyridazin-3-yl)piperidin-4-yl)methanone hydrochloride suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. 4-(2.3-Dihydroxy-propylamino)-6-methyl-benzol-1.3-disulfonsaeure-diamid vendor & factory.